T1	Participants 40 81	patients with fibrocystic breast disease]
T2	Participants 156 192	patients with fibrocystic mastopathy
T3	Participants 215 268	Patients with diagnosis of fibrocystic breast disease
T4	Participants 749 811	39 patients with alpha dihidroergocriptine and 38 with placebo
